Tecartherapy® in the diabetic foot
The treatment with Tecartherapy® gives relief to diabetic patients with cutaneous lesions of the foot, a common complication of this pathology in the most serious stages. In fact, the treatment is able to reduce pain, where present, and to accelerate wound healing.
Abstract The aim of this study is to evaluate the effects of the use of Tecartherapy® in the management of diabetic foot ulcers. 20 patients with neuroischemic ulcers, Wagner class II or III, were divided into two groups: group A was treated with Tecartherapy® and conventional local therapy and group B was treated with placebo Tecartherapy®, plus conventional local therapy. From the analysis of the collected data, we observed a marked improvement of the algic symptoms, when present, in the patients treated with Tecartherapy ®, in addition to a more rapid wound healing.
Source: E. Cavani et al, La Tecarterapia® nel piede diabetico, Vasculopatia diabetica, 2010